
|Articles|November 1, 1999
Supplements and Featured Publications
- The Clinical and Economic Impact of Pneumococcal Disease in the Pediatric Population
- Volume 5
- Issue 17 Suppl
Participating Faculty
Advertisement
Articles in this issue
over 26 years ago
Introductionover 26 years ago
Epidemiology of Pneumococcal Diseaseover 26 years ago
The Costs of Antimicrobial Treatment Failure in Acute Otitis Mediaover 26 years ago
Prevention of Pneumococcal Disease in High-Risk Pediatric Groupsover 26 years ago
The Clinical Impact of Pneumococcal Conjugate Vaccinesover 26 years ago
Economic Impact of Pneumococcal Conjugate Vaccine in Managed Careover 26 years ago
Into the Era of the Pneumococcal Conjugate Vaccineover 26 years ago
Selected Abstractsover 26 years ago
CME Quizover 26 years ago
BibliographyAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies
2
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
3
CMS Proposes Permanent Rules for Medicare Drug Price Negotiation
4
AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike
5





